Exelon director Lillie acquires 6 stock-linked units

The deferred equivalents are scheduled for cash settlement at a 1-for-1 rate when her board service ends.

Rhea-AI Filing Summary

Exelon Corp director Charisse R. Lillie acquired 6 deferred phantom share equivalents on September 30, 2026. Her reported balance was 3,941 equivalents, including 39 additional equivalents accrued through automatic dividend reinvestment. The equivalents are held in her Exelon stock fund account within a multi-fund, non-qualified deferred compensation plan and will be settled for cash on a 1-for-1 basis when her board service ends.

Insider Trade Summary

Grant/Award: 6 shares

Grant/Award 1 txn

Insider Lillie Charisse R

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred phantom share equivalents F1, F2	6	$40.40	$242.40

Holdings After Transaction: Deferred phantom share equivalents — 3,941 contracts (Direct)

Footnotes (2)

1. F1. Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. Phantom share equivalents will be settled for cash on a 1 for 1 basis upon the termination of the reporting person's service to the board of directors.
2. F2. Balance includes 39 additional phantom share equivalents accrued to the account through automatic dividend reinvestment.

Key Figures

Deferred phantom share equivalents acquired: 6 equivalents Reported balance: 3,941 equivalents Additional equivalents accrued: 39 equivalents +1 more

4 metrics

Deferred phantom share equivalents acquired 6 equivalents September 30, 2026

Reported balance 3,941 equivalents Balance includes additional equivalents accrued through automatic dividend reinvestment

Additional equivalents accrued 39 equivalents Through automatic dividend reinvestment

Cash settlement basis 1-for-1 Upon termination of service to the board of directors

Key Terms

Deferred phantom share equivalents, non-qualified deferred compensation plan, automatic dividend reinvestment

3 terms

Deferred phantom share equivalents financial

"Phantom share equivalents held in the reporting person's Exelon stock fund account"

non-qualified deferred compensation plan financial

"part of a multi-fund, non-qualified deferred compensation plan"

An arrangement where an employer agrees to pay part of an employee’s salary or bonus at a later date, often to attract or keep key staff. Think of it as a company IOU or a delayed paycheck held on the company’s books rather than in a protected retirement account; investors care because these promises create future cash obligations that are typically unsecured and depend on the company’s financial health, affecting risk, liabilities, and cash-flow planning.

automatic dividend reinvestment financial

"accrued to the account through automatic dividend reinvestment"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many deferred phantom share equivalents did an Exelon (EXC) director acquire?

Exelon director Charisse R. Lillie acquired 6 deferred phantom share equivalents on September 30, 2026. Her reported balance was 3,941 equivalents, including 39 accrued through automatic dividend reinvestment.

How are Charisse R. Lillie's Exelon phantom share equivalents settled?

The phantom share equivalents will be settled for cash on a 1-for-1 basis when Charisse R. Lillie's service on Exelon's board of directors ends. They are held in her Exelon stock fund account within a multi-fund, non-qualified deferred compensation plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/01/2026 - 04:08 PM Accepted by SEC EDGAR 10/01/2026 - 04:08 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lillie Charisse R

(Last) (First) (Middle)

10 S DEARBORN STREET

54TH FLOOR

(Street)

CHICAGO ILLINOIS 60603

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
EXELON CORP [ EXC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred phantom share equivalents	(1)	09/30/2026		A		6		(1)	(1)	Common Stock	6	$40.4	3,941(2)	D

Explanation of Responses:

1. Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. Phantom share equivalents will be settled for cash on a 1 for 1 basis upon the termination of the reporting person's service to the board of directors.

2. Balance includes 39 additional phantom share equivalents accrued to the account through automatic dividend reinvestment.

Remarks:

	David T. Skinner, attorney-in-fact for Charisse R Lillie	10/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)